A bankruptcy judge has approved the sale of 23andMe, the genetics company, to the TTAM Research Institute, a nonprofit led by its former CEO Anne Wojcicki, for $305 million. This decision comes despite concerns raised by the California Attorney General, who stated that the sale may not comply with state law. Advocates argue that the sale will help protect consumer DNA and data, while critics highlight ongoing issues with health data protection and cybersecurity vulnerabilities, as evidenced by recent incidents involving genetic data breaches. The legal battles surrounding the company’s DNA data continue, highlighting the need for clearer data privacy regulations.